Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

BB 882

Known as: BB-882 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
The aim of the present study was to investigate the potential effect of treatment with a platelet-activating factor (PAF… Expand
Highly Cited
2001
Highly Cited
2001
BACKGROUND The role of cell adhesion molecules and transmigration of PMNs through the endothelial barrier is probably essential… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Highly Cited
2000
Highly Cited
2000
Objective: To evaluate the safety and efficacy of the platelet‐activating factor receptor antagonist BB‐882 in the treatment of… Expand
Highly Cited
1999
Highly Cited
1999
Endothelial barrier dysfunction is a critical link in the development of tissue injury and organ dysfunction, via upregulation… Expand
1998
1998
Platelet-activating factor (PAF) may play a critical and primary role in the pathogenesis of acute pancreatitis and pancreatitis… Expand
1996
1996
Acute pancreatitis is associated with the development of pulmonary dysfunction in a number of patients. The aim of this study was… Expand
1996
1996
Objective: To assess the anti-inflammatory action of lexipafant (BB-882), a platelet activating factor antagonist, in an animal… Expand
Review
1996
Review
1996
  • L. Curtis
  • Advances in experimental medicine and biology
  • 1996
  • Corpus ID: 35315157
Acute pancreatitis remains a poorly understood and hence unsatisfactorily treated condition1. In general this is a mild self… Expand
1996
1996
&NA; Acute pancreatitis is associated with the development of pulmonary dysfunction in a number of patients. The aim of this… Expand
  • figure 1
  • figure 3
  • figure 2
  • figure 4
  • figure 5
Highly Cited
1994
Highly Cited
1994
The effect of a potent platelet‐activating factor (PAF) antagonist, BB‐882, on an experimental model of acute pancreatitis… Expand